RESULTS OF LAPAROSCOPIC THORACOABDOMINAL ESOPHAGECTOMY FOR ESOPHAGEAL CANCER WITH PRE-OPERATIVE CHEMORADIOTHERAPY AT VIET DUC FRIENDSHIP HOSPITAL
Main Article Content
Abstract
Objectives: Comment on the response to preoperative chemoradiotherapy in a group of patients undergoing minimally invasive surgery for esophageal cancer at Viet Duc Friendship Hospital from 2017 to 2022 and evaluate the surgical outcomes in this patient group. Subject and methods: A descriptive retrospective study was conducted on 40 patients with esophageal cancer located in the middle third to lower third of the esophagus who underwent preoperative chemoradiotherapy followed by minimally invasive surgery for esophageal cancer. Results: The rates of complete response and partial response were 37.5% and 62.5% respectively. The response rates in patients with different histological subtypes were statistically significant with a p-value < 0.05. The duration of the interval between the end of radiotherapy and surgery had a significant impact on the response rate, with a statistically significant p-value of <0.05. The average duration of surgery was 310.0 ± 34.5 minutes, and the average blood loss was 102.75 ± 58.6 ml. The average number of lymph nodes harvested during the entire surgical procedure was 19.38 ± 11.31, with a minimum of 5 nodes and a maximum of 69 nodes. The R0 resection rate was 100%. The postoperative complication rate was 32.5%, with respiratory complications accounting for 22.5%. The average additional survival time was 48.4 ± 4.8 months. The estimated average survival rates at 1 year, 3 years, and 5 years were 76.9%, 61.9%, and 51.1%, respectively. The extent of invasion, lymph node metastasis, histological differentiation, and especially the response rate after radiotherapy significantly influenced the additional survival time with a p-value of <0.05.
Article Details
References
2. Nguyễn Thị Hà (2021), Kết quả hóa xạ trị đồng thời tiền phẫu ung thư thực quản 1/3 giữa-dưới giai đoạn II, III tại bệnh viện TWQĐ 108, Luận văn thạc sỹ y học, Trường đại học Y Hà Nội.
3. Phạm Quang Anh (2021). Đánh giá kết quả hóa xạ trị đồng thời tiền phẫu ung thư biểu mô thực quản 1/3 giữa dưới, Luận văn thạc sỹ y học, Trường đại học Y Hà Nội.
4. Castoro C, Scarpa M, Cagol M, et al. Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary? J Gastrointest Surg. 2013;17(8):1375-1381. doi:10.1007/s11605-013-2269-3
5. Taketa T, Correa AM, Suzuki A, et al. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology. 2012;83 (5):300-304. doi:10.1159/000341353
6. Warner S, Chang YH, Paripati H, et al. Outcomes of Minimally Invasive Esophagectomy in Esophageal Cancer After Neoadjuvant Chemoradiotherapy. The Annals of Thoracic Surgery. 2014;97(2): 439-445. doi: 10.1016/j. athoracsur.2013.09.042
7. Shapiro J, van Hagen P, Lingsma HF, et al. Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer. Annals of Surgery. 2014;260(5):807. doi: 10.1097/SLA. 0000000000000966
8. Liu G, Han Y, Peng L, Wang K, Fan Y. Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study. J Cardiothorac Surg. 2019;14:97. doi:10.1186/ s13019-019-0920-0
9. National Comprehensive Cancer Network. Esophageal and Esophagogastric Junction Cancers. Version 3.2023 August 29-2023. In: NCCN Clinical Practice Guidelines in Oncology [Internet].
10. Surendran S, Midha G, Paul N, et al. Feasibility, safety and oncological outcomes of minimally invasive oesophagectomy following neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma – Experience from a tertiary care centre. Journal of Minimal Access Surgery. 2022;18(4): 545. doi:10.4103/jmas. jmas_242_21